. 2019 Feb 6;10(2):535–547. doi: 10.1007/s13300-019-0578-6
© The Author(s) 2019
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Fig. 5.
Fasting C-peptide changes between the ABM-MNC therapy and control group